1-20 of 22
Reid Merryman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of prognostic factors and survival outcomes in patients with Relapsed/Refractory (R/R) large B-cell lymphomas (LBCLs) treated with epcoritamab

Free
Allison Bock, Lei Feng, Ayushi Chauhan, Lorenzo Falchi, Reid Merryman, Sonia Godbole, Swetha Thiruvengadam, Andrew Jallouk, Ajay Major, Christopher D'Angelo, Amy Ayers, Omnia Farahat, Steven Bair, Matthew Lunning, Shakthi Bhaskar, Alex Herrera, Yazeed Sawalha, Jennifer Crombie, Gilles Salles, Narendranath Epperla, Sairah Ahmed
Journal: Blood
Blood (2025) 146 (Supplement 1): 3739.
https://doi.org/10.1182/blood-2025-3739
Published: 2025
Journal Articles

Phase I/II study of acalabrutinib, venetoclax, and obinutuzumab in patients with relapsed/refractory and previously untreated Mantle Cell Lymphoma (MAVO)

Free
Austin Kim, Peter Riedell, Christine Ryan, Robert Redd, Clare Phinney, Juniper Mai, Samantha Pazienza, Caitlin Bravo, Vanessa Kats, Salah Abdulkarim, Susan Waisgerber, Reid Merryman, David Fisher, Inhye Ahn, Jennifer Crombie, Oreofe Odejide, Ann LaCasce, Caron Jacobson, Eric Jacobsen, Erin Parry, David Qualls, Amy Bessnow, Matthew S Davids, Jennifer Brown, Jon Arnason, Michael Leukam, Philippe Armand, Justin Kline, Mark Murakami
Journal: Blood
Blood (2025) 146 (Supplement 1): 664.
https://doi.org/10.1182/blood-2025-664
Published: 2025
Journal Articles

Glofitamab and obinutuzumab (GLOBIN) as first-line therapy for patients with high-tumor burden follicular lymphoma: First results of a multicenter phase II trial

Free
Reid Merryman, Gottfried von Keudell, Robert Redd, Heather Walker, Jenna Mahns, Samantha Normilus, Siri Sagedahl, Ioulia Vogiatzi, Mingzeng Zhang, Emily Sumpena, Weihsin Chuan, Inhye Ahn, Amy Bessnow, Jennifer Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Hua-Jay Cherng, Mark Murakami, Philippe Armand, Joshua Brody
Journal: Blood
Blood (2025) 146 (Supplement 1): 3602.
https://doi.org/10.1182/blood-2025-3602
Published: 2025
Journal Articles

EO2463 (EO) peptide immunotherapy combined with rituximab (R) for first-line treatment of low-tumor burden follicular lymphoma (FL): A feasibility evaluation in Study EONHL1-20/sidney (NCT04669171)

Free
Stephen Smith, Francesc Bosch Albareda, Danielle Wallace, Jose Villasboas Bisneto, Carlos Grande, Jean Pierre Marolleau, Reid Merryman, Luca Arcaini, Antonio Pinto, Norma Gutiérrez, Brian Till, Cristina García Herce, Maria Rocio Figueroa Mora, Pierre Morel, Sara Rattotti, Philippe Rinaudo, Jean-Marie Carpier, Jan Fagerberg, Pier Luigi Zinzani, Philippe Armand, Jonathan Friedberg, Stephen Ansell
Journal: Blood
Blood (2025) 146 (Supplement 1): 3594.
https://doi.org/10.1182/blood-2025-3594
Published: 2025
Journal Articles

Multicenter real-world outcomes in limited stage (LS) diffuse large B-cell lymphoma (DLBCL) treated with abbreviated immunochemotherapy

Free
Hua-Jay Cherng, Drew Gerber, Chijioke Nze, Shahzeem Bhayani, David Russler-Germain, Ahmed Alnughmush, Paul Hampel, Kelsey Kille, Danielle Wallace, David Qualls, Reid Merryman, Jaden Brooks, Allison Bock, Juan Ramirez, Yumeng Zhang, Julio Chavez, Katelynn Granger, Katherine Antel, Cassandra Duarte, Ajay Major, Sirui Ma, Michael Spinner, Alyssa Mackay, Bei Hu, Manoj Rai, Stephen Spurgeon, Benjamin Lee, Jean Doh, Elizabeth Brem, Nicole Altomare, Reem Karmali, Robert Ryan, Yun Kyoung Tiger, Jordan Carter, Daniel Landsburg, Swetha Thiruvengadam, Alan Skarbnik, Yun Choi, David Bond, Ravand Samaeekia, Helen Ma, Seda Tolu, Jennifer Amengual, Alex Herrera, Barbara Pro
Journal: Blood
Blood (2025) 146 (Supplement 1): 471.
https://doi.org/10.1182/blood-2025-471
Published: 2025
Journal Articles

Real world outcomes of sequencing bispecific antibodies (BsAb) in patients with relapsed / refractory follicular lymphoma (R/R FL): A multi-center cohort study from cubic consortium

Free
Chijioke Nze, Allison Bock, Yizhe Xu, Yuxin Zhao, Amy Ayers, Lorenzo Falchi, Reid Merryman, Steven Bair, Ajay Major, Andrew Jallouk, Swetha Thiruvengadam, Christopher D'Angelo, Matthew Lunning, Shakthi Bhaskar, Yazeed Sawalha, Omnia Farahat, Ayushi Chauhan, Geoffrey Shouse, Jennifer Crombie, Alex Herrera, Gilles Salles, Christopher Flowers, Sairah Ahmed, Narendranath Epperla
Journal: Blood
Blood (2025) 146 (Supplement 1): 1837.
https://doi.org/10.1182/blood-2025-1837
Published: 2025
Journal Articles

Outcomes of CD20xCD3 bispecific antibody therapy in adult patients with Relapsed/Refractory transformed indolent lymphoma

Free
Pierre Stephan, Karan Chohan, Robert Redd, Sairah Ahmed, Christopher Flowers, Ayushi Chauhan, Amy Ayers, Geoffrey Shouse, Swetha Thiruvengadam, Alex Herrera, Allison Bock, Narendranath Epperla, Shannon Buckley, Boyu Hu, Matthew Lunning, Gilles Salles, Lorenzo Falchi, Yazeed Sawalha, Sonia Godbole, Andrew Jallouk, Shakthi Bhaskar, Ajay Major, Steven Bair, Philippe Armand, Reid Merryman, Alexey Danilov, Jennifer Crombie
Journal: Blood
Blood (2025) 146 (Supplement 1): 5521.
https://doi.org/10.1182/blood-2025-5521
Published: 2025
Journal Articles

Real-world outcomes of mosunetuzumab use in indolent and aggressive lymphomas

Free
Andrew Jallouk, Lorenzo Falchi, Ayushi Chauhan, Geoffrey Shouse, Swetha Thiruvengadam, Yazeed Sawalha, Sonia Godbole, Ajay Major, Reid Merryman, Shakthi Bhaskar, Allison Bock, Amy Ayers, Omnia Farahat, Narendranath Epperla, Jennifer Crombie, Steven Bair, Alex Herrera, Christopher Flowers, Gilles Salles, Sairah Ahmed
Journal: Blood
Blood (2025) 146 (Supplement 1): 4515.
https://doi.org/10.1182/blood-2025-4515
Published: 2025
Journal Articles

Outcomes and prognostic factors in patients with follicular lymphoma treated with front-line bendamustine and rituximab

Free
Hari Raman, Robert Redd, Wendy Dixon, Pari Ahmadi, Inhye Ahn, Amy Bessnow, Jennifer Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Mark Murakami, Philippe Armand, Reid Merryman
Journal: Blood
Blood (2025) 146 (Supplement 1): 1812.
https://doi.org/10.1182/blood-2025-1812
Published: 2025
Journal Articles

Precise-HL trial: Personalized reduction of chemotherapy intensity through ctdna evaluation in advanced Hodgkin lymphoma

Free
Ryan Lynch, David Russler-Germain, Joseph Schroers-Martin, Alison Moskowitz, Reid Merryman, Azra Borogovac, Hongyan Du, Heather Rasmussen, Ranjana Advani, Ash Alizadeh, Philippe Armand, Nancy Bartlett, Alex Herrera, Matthew Mei, Sarah Rutherford, David Kurtz, Ted Gooley, Jenna Voutsinas, Ajay Gopal
Journal: Blood
Blood (2025) 146 (Supplement 1): 5408.
https://doi.org/10.1182/blood-2025-5408
Published: 2025
Journal Articles

Real world efficacy of mosunetuzumab in follicular lymphoma patients previously exposed to lenalidomide: A collaborative US bispecifics consortium study

Free
Tony Zhuang, Xiaowen Sun, Lei Feng, Lorenzo Falchi, Ayushi Chauhan, Amy Ayers, Omnia Farahat, Yazeed Sawalha, Geoffrey Shouse, Swetha Thiruvengadam, Steven Bair, Ajay Major, Shakthi Bhaskar, Andrew Jallouk, Allison Bock, Matthew Lunning, Jennifer Crombie, Narendranath Epperla, Alex Herrera, Alexey Danilov, Gilles Salles, Christopher Flowers, Sairah Ahmed, Paolo Strati, Reid Merryman
Journal: Blood
Blood (2025) 146 (Supplement 1): 5384.
https://doi.org/10.1182/blood-2025-5384
Published: 2025
Journal Articles

Immune cell dynamics following rituximab and epcoritamab as first-line therapy for patients with high-tumor burden follicular lymphoma

Free
Ioulia Vogiatzi, Emily Sumpena, Arsh Patel, Heather Walker, Rafaella Tringale, Robert Redd, Philippe Armand, Reid Merryman, Mark Murakami
Journal: Blood
Blood (2025) 146 (Supplement 1): 1790.
https://doi.org/10.1182/blood-2025-1790
Published: 2025
Journal Articles

Prior bendamustine exposure does not compromise clinical outcomes of bispecific antibody therapy in patients with relapsed/refractory non-Hodgkin lymphoma: A cubic consortium analysis

Free
Annie Xiao, Jarrod Smith, Jomel Meeko Manzano, Lu Chen, Allison Bock, Narendranath Epperla, Yazeed Sawalha, Andrew Jallouk, Shakthi Bhaskar, Lorenzo Falchi, Gilles Salles, Matthew Lunning, Jennifer Crombie, Reid Merryman, Steven Bair, Ajay Major, Amy Ayers, Christine Goth, Geoffrey Shouse, Christopher Flowers, Alexey Danilov, Alex Herrera, Ayushi Chauhan, Sairah Ahmed, Swetha Thiruvengadam, Vivek Patel
Journal: Blood
Blood (2025) 146 (Supplement 1): 6294.
https://doi.org/10.1182/blood-2025-6294
Published: 2025
Journal Articles

Immune population changes after glofitamab and obinutuzumab (GLOBIN) as first-line therapy for patients with follicular lymphoma and marginal zone lymphoma

Free
Emily Sumpena, Ioulia Vogiatzi, Arsh Patel, Heather Walker, Jenna Mahns, Robert Redd, Philippe Armand, Reid Merryman, Mark Murakami
Journal: Blood
Blood (2025) 146 (Supplement 1): 5344.
https://doi.org/10.1182/blood-2025-5344
Published: 2025
Journal Articles

EO2463 (EO) peptide immunotherapy in patients (pts) with newly diagnosed asymptomatic follicular lymphoma (FL) and marginal zone lymphoma (MZL): Study EONHL1-20/sidney (NCT04669171) primary endpoint lugano objective response analysis

Free
Jose Villasboas Bisneto, Reid Merryman, Stephen Smith, Danielle Wallace, Jean Pierre Marolleau, Luca Arcaini, Carlos Grande, Francesc Bosch Albareda, Antonio Pinto, Norma Gutiérrez, Brian Till, Maria Rocio Figueroa Mora, Pierre Morel, Sara Rattotti, Cristina García Herce, Philippe Rinaudo, Jean-Marie Carpier, Jan Fagerberg, Pier Luigi Zinzani, Jonathan Friedberg, Philippe Armand, Stephen Ansell
Journal: Blood
Blood (2025) 146 (Supplement 1): 5377.
https://doi.org/10.1182/blood-2025-5377
Published: 2025
Journal Articles

Rituximab and epcoritamab as first-line therapy for patients with high-tumor burden follicular lymphoma: Results of a multicenter phase II trial

Free
Reid Merryman, Danielle Wallace, Robert Redd, Heather Walker, Rafaella Tringale, Vanessa Kats, Siri Sagedahl, Ioulia Vogiatzi, Mingzeng Zhang, Emily Sumpena, Weihsin Chuan, Audrey Sigmund, Inhye Ahn, Amy Bessnow, Jennifer R. Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Sumana Devata, Carla Casulo, Kami Maddocks, Mark Murakami, Philippe Armand, Yazeed Sawalha
Journal: Blood
Blood (2025) 146 (Supplement 1): 464.
https://doi.org/10.1182/blood-2025-464
Published: 2025
Journal Articles

Sequencing CD20-directed bispecific antibody and CD19-directed CAR T cell therapy in large B cell lymphoma: A multicenter real-world study

Free
David Qualls, Andrew Jallouk, Geoffrey Shouse, Swetha Thiruvengadam, Omnia Farahat, Amy Ayers, Ayushi Chauhan, Reid Merryman, Ajay Major, Yazeed Sawalha, Narendranath Epperla, Matthew Lunning, Shakthi Bhaskar, Allison Bock, Steven Bair, Gilles Salles, Christopher Flowers, Alex Herrera, Lorenzo Falchi, Jennifer Crombie, Lei Feng, Sairah Ahmed
Journal: Blood
Blood (2025) 146 (Supplement 1): 3663.
https://doi.org/10.1182/blood-2025-3663
Published: 2025
Journal Articles

Baseline intratumoral CD4⁺ T-cell abundance and frequency correlates with durable clinical response to acalabrutinib, venetoclax, and obinutuzumab (AVO) treatment in Mantle Cell Lymphoma

Free
Mingzeng Zhang, Billie Porter, Kathleen Pfaff, Anne Carlisle, Grace Chen, Lydie Debaize, Salah Abdulkarim, Haocheng Wang, Juniper Mai, Alexa Batingana, Jenalyn Weekes, Paul Branch, Liliana Guerrero, Mikaela McDonough, Reid Merryman, Christine Ryan, Austin Kim, Scott Rodig, Mark Murakami
Journal: Blood
Blood (2025) 146 (Supplement 1): 3551.
https://doi.org/10.1182/blood-2025-3551
Published: 2025
Journal Articles

Identification of an optimal absolute lymphocyte count before bispecific antibody therapy for large B-cell lymphoma: A collaborative US bispecific consortium Study

Free
Kunhwa Kim, Zhouxuan Li, Wei Qiao, Amy Ayers, Zachary Hunzeker, Allison Bock, Ayushi Chauhan, Lorenzo Falchi, Reid Merryman, Swetha Thiruvengadam, Andrew Jallouk, Omnia Farahat, Steven Bair, Matthew Lunning, Shakthi Bhaskar, Yazeed Sawalha, Jennifer Crombie, Narendranath Epperla, Geoffrey Shouse, Sairah Ahmed, Paolo Strati, Ajay Major
Journal: Blood
Blood (2025) 146 (Supplement 1): 1967.
https://doi.org/10.1182/blood-2025-1967
Published: 2025
Journal Articles

Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil

Free
Clinical Trials & Observations
Charles Herbaux, Reid Merryman, Steven Devine, Philippe Armand, Roch Houot, Franck Morschhauser, Bradley Haverkos
Journal: Blood
Blood (2018) 132 (1): 9–16.
https://doi.org/10.1182/blood-2018-02-811174
Published: 2018